首页 > 最新文献

Journal of Medical Toxicology最新文献

英文 中文
Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose. 一名服用喹硫平即释药物过量的患者因药理作用而导致临床病程延长。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-02 DOI: 10.1007/s13181-024-01029-6
Fumiya Inoue, Yuji Okazaki, Kyungko Huh, Toshihisa Ichiba, Takuyo Chiba, Akira Namera

Introduction: Quetiapine is available in both immediate-release (IR) and extended-release (XR) formulations. Quetiapine XR overdose is known to cause delayed increase in serum quetiapine concentrations. However, it is not certain whether quetiapine IR overdose would similarly cause a delayed increase in serum quetiapine concentrations.

Case report: A 57-year-old woman with depression who was taking half a tablet of 25 mg quetiapine IR daily was transported to our emergency department with a complaint of disturbance of consciousness 12 h after a quetiapine IR overdose. On arrival, her initial vital signs were heart rate of 116 beats per minute, blood pressure of 77/43 mm Hg, and oxygen saturation of 91% under 10 L oxygen administration. Whole body plain computed tomography showed a large amount of gastric hyperdense content suggesting pharmacobezoar with a volume of 71.2 ml. After treatment with respiratory and circulatory support, gastric lavage was performed. Her disturbance of consciousness persisted until day 5, and she was extubated on day 7. The serum concentrations of quetiapine were 2690 ng/mL at 12 h after overdose, 5940 ng/mL at 40 h, and 350 ng/mL at 124 h after overdose. Serum concentrations of other co-ingestions were all below lethal levels.

Conclusion: A massive quetiapine IR overdose with pharmacobezoars can cause a delayed increase in serum quetiapine concentrations.

简介喹硫平有速释(IR)和缓释(XR)两种剂型。已知喹硫平 XR 药物过量会导致血清中喹硫平浓度延迟升高。然而,尚不确定喹硫平 IR 药物过量是否同样会导致血清喹硫平浓度延迟升高:一名每天服用半片 25 毫克喹硫平 IR 的 57 岁女性抑郁症患者在服用喹硫平 IR 过量 12 小时后因意识障碍被送往我院急诊科。到达时,她的初始生命体征为心率 116 次/分,血压 77/43 mm Hg,10 L 氧气饱和度为 91%。全身平扫计算机断层扫描显示,胃内有大量高密度内容物,提示为药醉,体积为 71.2 毫升。经过呼吸和循环支持治疗后,进行了洗胃。她的意识障碍一直持续到第 5 天,第 7 天拔除了插管。喹硫平的血清浓度在服药过量后 12 小时为 2690 纳克/毫升,40 小时为 5940 纳克/毫升,124 小时为 350 纳克/毫升。其他合剂的血清浓度均低于致死水平:结论:大量服用喹硫平IR并同时服用药佐剂可导致血清喹硫平浓度延迟升高。
{"title":"Pharmacobezoar Associated Prolonged Clinical Course in a Patient with Immediate Release Quetiapine Overdose.","authors":"Fumiya Inoue, Yuji Okazaki, Kyungko Huh, Toshihisa Ichiba, Takuyo Chiba, Akira Namera","doi":"10.1007/s13181-024-01029-6","DOIUrl":"10.1007/s13181-024-01029-6","url":null,"abstract":"<p><strong>Introduction: </strong>Quetiapine is available in both immediate-release (IR) and extended-release (XR) formulations. Quetiapine XR overdose is known to cause delayed increase in serum quetiapine concentrations. However, it is not certain whether quetiapine IR overdose would similarly cause a delayed increase in serum quetiapine concentrations.</p><p><strong>Case report: </strong>A 57-year-old woman with depression who was taking half a tablet of 25 mg quetiapine IR daily was transported to our emergency department with a complaint of disturbance of consciousness 12 h after a quetiapine IR overdose. On arrival, her initial vital signs were heart rate of 116 beats per minute, blood pressure of 77/43 mm Hg, and oxygen saturation of 91% under 10 L oxygen administration. Whole body plain computed tomography showed a large amount of gastric hyperdense content suggesting pharmacobezoar with a volume of 71.2 ml. After treatment with respiratory and circulatory support, gastric lavage was performed. Her disturbance of consciousness persisted until day 5, and she was extubated on day 7. The serum concentrations of quetiapine were 2690 ng/mL at 12 h after overdose, 5940 ng/mL at 40 h, and 350 ng/mL at 124 h after overdose. Serum concentrations of other co-ingestions were all below lethal levels.</p><p><strong>Conclusion: </strong>A massive quetiapine IR overdose with pharmacobezoars can cause a delayed increase in serum quetiapine concentrations.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"430-433"},"PeriodicalIF":2.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11436767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141875095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of Physostigmine for Pediatric Antimuscarinic Poisoning. Physostigmine 用于治疗小儿抗心绞痛药中毒的安全性。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-09-01 Epub Date: 2024-01-24 DOI: 10.1007/s13181-024-00988-0
Sarah Huber, Robert Avera, Shannon Penfound, Adam Overberg, Kristine Nañagas

Introduction: Physostigmine fell out of widespread use in the 1980s due to safety concerns; however, more recent research has demonstrated that its safety profile is better than previously thought. These studies have mainly included adults. We theorized that improved safety data may lead to more acceptance. Our objectives, therefore, were to characterize current frequency of use of physostigmine in pediatric patients as well as to study adverse effect rates in a national pediatric patient population.

Methods: The National Poison Data System was queried for cases of patients aged 0-18 years that involved single-substance exposures to antimuscarinic xenobiotics that were reported to a poison center between January 1, 2000, and December 31, 2020. Cases were stratified into groups by therapy received: benzodiazepines alone, benzodiazepines and physostigmine, physostigmine alone, or no physostigmine or benzodiazepines. Patient demographics, clinical effects, and medical outcomes were analyzed.

Results: A total of 694,132 cases were reviewed, and 150,075 were included for analysis. Nearly 5% (7562/150,075) of patients received specific pharmacological therapy with benzodiazepines, physostigmine, or both. A benzodiazepine as a single agent was the most frequently used pharmacologic therapy (92% of 7562). Among patients receiving any pharmacological therapy, only 8.3% (n = 627) of patients received physostigmine. Frequency of serious outcomes significantly increased across the study period among patients receiving benzodiazepines alone or with physostigmine. There was no increase in serious outcomes among patients receiving only physostigmine.

Conclusions: Physostigmine frequency of use was low overall, but when used, was associated with less severe outcomes when compared to benzodiazepines.

简介:上世纪 80 年代,由于安全性问题, Physostigmine 不再被广泛使用;不过,最近的研究表明,其安全性比以前想象的要好。这些研究主要涉及成年人。我们推测,安全性数据的改善可能会让更多人接受它。因此,我们的目标是了解目前儿科患者使用波司的明的频率,并研究全国儿科患者的不良反应率:方法:我们从全国毒物数据系统中查询了 2000 年 1 月 1 日至 2020 年 12 月 31 日期间向毒物中心报告的 0-18 岁患者单次接触抗马司卡因类异生物体的病例。根据所接受的治疗将病例分为以下几组:单独使用苯二氮卓类药物、苯二氮卓类药物和波司的明、单独使用波司的明或不使用波司的明或苯二氮卓类药物。对患者的人口统计学特征、临床效果和医疗结果进行了分析:共审查了 694 132 个病例,其中 150 075 个病例被纳入分析范围。近 5%(7562/150,075 例)的患者接受了苯二氮卓、扑斯的明或两者兼用的特定药物治疗。苯二氮卓类药物是最常用的药物疗法(7562 人中占 92%)。在接受任何药物治疗的患者中,只有 8.3% 的患者(n = 627)接受了波司的明治疗。在整个研究期间,单独使用苯二氮卓类药物或同时使用波司替明的患者出现严重后果的频率明显增加。结论:在研究期间,仅使用苯二氮卓类药物或同时使用芬戈斯的明的患者中,出现严重后果的频率没有增加:结论:总体而言,使用菲泊斯的明的频率较低,但与苯二氮卓类药物相比,使用菲泊斯的明导致的严重后果较少。
{"title":"Safety of Physostigmine for Pediatric Antimuscarinic Poisoning.","authors":"Sarah Huber, Robert Avera, Shannon Penfound, Adam Overberg, Kristine Nañagas","doi":"10.1007/s13181-024-00988-0","DOIUrl":"10.1007/s13181-024-00988-0","url":null,"abstract":"<p><strong>Introduction: </strong>Physostigmine fell out of widespread use in the 1980s due to safety concerns; however, more recent research has demonstrated that its safety profile is better than previously thought. These studies have mainly included adults. We theorized that improved safety data may lead to more acceptance. Our objectives, therefore, were to characterize current frequency of use of physostigmine in pediatric patients as well as to study adverse effect rates in a national pediatric patient population.</p><p><strong>Methods: </strong>The National Poison Data System was queried for cases of patients aged 0-18 years that involved single-substance exposures to antimuscarinic xenobiotics that were reported to a poison center between January 1, 2000, and December 31, 2020. Cases were stratified into groups by therapy received: benzodiazepines alone, benzodiazepines and physostigmine, physostigmine alone, or no physostigmine or benzodiazepines. Patient demographics, clinical effects, and medical outcomes were analyzed.</p><p><strong>Results: </strong>A total of 694,132 cases were reviewed, and 150,075 were included for analysis. Nearly 5% (7562/150,075) of patients received specific pharmacological therapy with benzodiazepines, physostigmine, or both. A benzodiazepine as a single agent was the most frequently used pharmacologic therapy (92% of 7562). Among patients receiving any pharmacological therapy, only 8.3% (n = 627) of patients received physostigmine. Frequency of serious outcomes significantly increased across the study period among patients receiving benzodiazepines alone or with physostigmine. There was no increase in serious outcomes among patients receiving only physostigmine.</p><p><strong>Conclusions: </strong>Physostigmine frequency of use was low overall, but when used, was associated with less severe outcomes when compared to benzodiazepines.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"263-270"},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139541397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Registries and Large Databases for Toxicology Research. 将登记册和大型数据库用于毒理学研究。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-09-01 Epub Date: 2024-02-16 DOI: 10.1007/s13181-024-00997-z
Maryann Mazer-Amirshahi, Daniel A Laub, Mark B Mycyk

The advancement of medical toxicology knowledge has traditionally relied on case reports and case series because of the ethical challenges involved in studying poisoned patients. The growing availability of several large databases and registries now allows researchers to describe and analyze patterns in poisoned patients who share a particular exposure, outcome, or condition. A large database or registry can be useful in generating hypotheses, supporting extramural funding applications, and planning more rigorous studies. Knowing how to access and interpret data in registries such as NPDS, NHAMCS, and HCUP is essential for all stakeholders engaged in medical toxicology research. This review describes the strengths and limitations of different toxicology-relevant registries and databases and how to leverage these powerful tools to advance the science in the field of medical toxicology.

医学毒理学知识的发展历来依赖于病例报告和系列病例,因为研究中毒患者涉及伦理挑战。现在,越来越多的大型数据库和登记处允许研究人员描述和分析具有特定暴露、结果或状况的中毒患者的模式。大型数据库或登记处有助于提出假设、支持校外资助申请以及规划更严格的研究。了解如何访问和解释 NPDS、NHAMCS 和 HCUP 等登记册中的数据,对于从事医学毒理学研究的所有相关人员来说都至关重要。本综述介绍了不同毒理学相关登记处和数据库的优势和局限性,以及如何利用这些强大的工具来推动医学毒理学领域的科学发展。
{"title":"Use of Registries and Large Databases for Toxicology Research.","authors":"Maryann Mazer-Amirshahi, Daniel A Laub, Mark B Mycyk","doi":"10.1007/s13181-024-00997-z","DOIUrl":"10.1007/s13181-024-00997-z","url":null,"abstract":"<p><p>The advancement of medical toxicology knowledge has traditionally relied on case reports and case series because of the ethical challenges involved in studying poisoned patients. The growing availability of several large databases and registries now allows researchers to describe and analyze patterns in poisoned patients who share a particular exposure, outcome, or condition. A large database or registry can be useful in generating hypotheses, supporting extramural funding applications, and planning more rigorous studies. Knowing how to access and interpret data in registries such as NPDS, NHAMCS, and HCUP is essential for all stakeholders engaged in medical toxicology research. This review describes the strengths and limitations of different toxicology-relevant registries and databases and how to leverage these powerful tools to advance the science in the field of medical toxicology.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"299-305"},"PeriodicalIF":2.5,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139746746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is EGD Needed in all Patients after Suicidal or Exploratory Caustic Ingestions? 自杀性或探查性摄入腐蚀性物质后,是否所有患者都需要做胃肠造影?
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-27 Epub Date: 2024-04-22 DOI: 10.1007/s13181-024-01003-2
Michael Levine, Yaron Finkelstein, William J Trautman, Dazhe Cao, Evan Schwarz, Ari Filip, Leanne Cook, Sameer Arbussattar Pathan, Cherie Obilom, Jim Liu, Joseph Yanta, Neta Cohen, Stephen H Thomas

Background: Caustic ingestions are relatively uncommon, but remain a significant source of morbidity. Patients with caustic injury often undergo an urgent EGD, although it is not clear if an EGD is routinely needed in an asymptomatic patient. The study has two primary objectives; 1) to determine the utility of routine EGD in asymptomatic suicidal caustic ingestions; 2) to determine if asymptomatic unintentional acidic ingestions can be managed with observation alone, similar to basic ingestions.

Methods: This retrospective study, which took place at 14 hospitals in three countries evaluated all patients who presented with a caustic ingestion between 2014-2020. The presence of symptoms and esophageal injury, demographic information, pH of ingested substance, reason for the ingestion, and outcome were recorded.

Results: 409 patients were identified; 203 (46.9%) were male. The median (IQR) age was 18 (4-31) years; overall range 10 months to 78 years. Suicidal ingestions accounted for 155 (37.9%) of cases. Dysphagia or dysphonia were more likely in those with significant esophageal injury compared to those without (59.3% vs. 12.6% respectively; OR 10.1; 95% CI 4.43-23.1). Among 27 patients with significant esophageal injury, 48% were found in suicidal patients, compared with 51.9% in non-suicidal patients (p = NS). On multivariate regression, there was no difference in the rate of significant esophageal injury among suicidal vs. non suicidal patients (aOR 1.55; p = 0.45, 95% CI 0.45-5.33). Most ingestions involved basic substances (332/409; 81.2%). Unknown or mixed ingestions accounted for 25 (6.11%) of the ingestions. Significant esophageal burns were found in 6/52 (11.5%) of acid ingestions, compared with 21/332 (6.3%) of basic ingestions. Of the 42 cases of acidic ingestions without dysphagia or odynophagia, 2 (4.8%; 0.58-16.1%) had significant esophageal burns, compared with 9 (3.2%; 95% CI 1.4-5.9%) of the 284 basic ingestions; p = 0.64). On multivariate logistic regression, patients with acidic ingestions were not more likely to experience a significant burn (aOR 1.7; p = 0.11, 95% CI 0.9-3.1) compared to those with basic ingestions. No patient with significant esophageal burns was asymptomatic.

Conclusion: In this study, there was no statistical differences in the rates of significant burns between acidic and basic caustic ingestions. There were no significant esophageal injuries noted among asymptomatic patients.

背景:腐蚀性物质摄入相对来说并不常见,但仍然是一个重要的发病原因。腐蚀性物质损伤患者通常会紧急接受胃肠道造影检查,但无症状患者是否需要常规接受胃肠道造影检查尚不清楚。本研究有两个主要目标:1)确定常规胃肠道造影术对无症状自杀性腐蚀性物质摄入的效用;2)确定无症状无意摄入酸性物质是否可以像基本摄入一样仅通过观察来处理:这项回顾性研究在三个国家的 14 家医院进行,评估了 2014-2020 年间所有因摄入腐蚀性物质而就诊的患者。研究记录了患者的症状和食道损伤、人口统计学信息、摄入物质的 pH 值、摄入原因和结果:结果:共发现 409 名患者,其中 203 名(46.9%)为男性。年龄中位数(IQR)为18(4-31)岁;总体年龄范围为10个月至78岁。自杀性摄食占 155 例(37.9%)。与无明显食管损伤的患者相比,有明显食管损伤的患者更容易出现吞咽困难或发音障碍(分别为 59.3% 对 12.6%;OR 10.1;95% CI 4.43-23.1)。在 27 名食管有明显损伤的患者中,自杀患者占 48%,而非自杀患者占 51.9%(P = NS)。多变量回归结果显示,自杀与非自杀患者的食管明显损伤率没有差异(aOR 1.55;p = 0.45,95% CI 0.45-5.33)。大多数摄入物涉及基本物质(332/409;81.2%)。未知或混合摄入占 25 例(6.11%)。6/52(11.5%)例摄入酸性物质后发现食管严重灼伤,而21/332(6.3%)例摄入碱性物质后发现食管严重灼伤。在 42 例无吞咽困难或吞咽困难的酸性食入病例中,有 2 例(4.8%;0.58-16.1%)有明显的食管灼伤,而在 284 例基本食入病例中,有 9 例(3.2%;95% CI 1.4-5.9%)有明显的食管灼伤;P = 0.64)。在多变量逻辑回归中,与基本型食道摄入相比,酸性食道摄入患者发生严重灼伤的可能性并不大(aOR 1.7;p = 0.11,95% CI 0.9-3.1)。没有食道严重烧伤患者没有症状:在这项研究中,酸性和碱性腐蚀剂摄入造成的严重灼伤率没有统计学差异。无症状患者的食管没有明显损伤。
{"title":"Is EGD Needed in all Patients after Suicidal or Exploratory Caustic Ingestions?","authors":"Michael Levine, Yaron Finkelstein, William J Trautman, Dazhe Cao, Evan Schwarz, Ari Filip, Leanne Cook, Sameer Arbussattar Pathan, Cherie Obilom, Jim Liu, Joseph Yanta, Neta Cohen, Stephen H Thomas","doi":"10.1007/s13181-024-01003-2","DOIUrl":"10.1007/s13181-024-01003-2","url":null,"abstract":"<p><strong>Background: </strong>Caustic ingestions are relatively uncommon, but remain a significant source of morbidity. Patients with caustic injury often undergo an urgent EGD, although it is not clear if an EGD is routinely needed in an asymptomatic patient. The study has two primary objectives; 1) to determine the utility of routine EGD in asymptomatic suicidal caustic ingestions; 2) to determine if asymptomatic unintentional acidic ingestions can be managed with observation alone, similar to basic ingestions.</p><p><strong>Methods: </strong>This retrospective study, which took place at 14 hospitals in three countries evaluated all patients who presented with a caustic ingestion between 2014-2020. The presence of symptoms and esophageal injury, demographic information, pH of ingested substance, reason for the ingestion, and outcome were recorded.</p><p><strong>Results: </strong>409 patients were identified; 203 (46.9%) were male. The median (IQR) age was 18 (4-31) years; overall range 10 months to 78 years. Suicidal ingestions accounted for 155 (37.9%) of cases. Dysphagia or dysphonia were more likely in those with significant esophageal injury compared to those without (59.3% vs. 12.6% respectively; OR 10.1; 95% CI 4.43-23.1). Among 27 patients with significant esophageal injury, 48% were found in suicidal patients, compared with 51.9% in non-suicidal patients (p = NS). On multivariate regression, there was no difference in the rate of significant esophageal injury among suicidal vs. non suicidal patients (aOR 1.55; p = 0.45, 95% CI 0.45-5.33). Most ingestions involved basic substances (332/409; 81.2%). Unknown or mixed ingestions accounted for 25 (6.11%) of the ingestions. Significant esophageal burns were found in 6/52 (11.5%) of acid ingestions, compared with 21/332 (6.3%) of basic ingestions. Of the 42 cases of acidic ingestions without dysphagia or odynophagia, 2 (4.8%; 0.58-16.1%) had significant esophageal burns, compared with 9 (3.2%; 95% CI 1.4-5.9%) of the 284 basic ingestions; p = 0.64). On multivariate logistic regression, patients with acidic ingestions were not more likely to experience a significant burn (aOR 1.7; p = 0.11, 95% CI 0.9-3.1) compared to those with basic ingestions. No patient with significant esophageal burns was asymptomatic.</p><p><strong>Conclusion: </strong>In this study, there was no statistical differences in the rates of significant burns between acidic and basic caustic ingestions. There were no significant esophageal injuries noted among asymptomatic patients.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"256-262"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACMT Comment on Recent Guidance on PFAS Laboratory Testing. ACMT 就 PFAS 实验室测试最新指南发表评论。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-27 Epub Date: 2024-04-18 DOI: 10.1007/s13181-024-01004-1
John W Downs, Nicholas E Nacca, Andrew I Stolbach, Michael G Holland
{"title":"ACMT Comment on Recent Guidance on PFAS Laboratory Testing.","authors":"John W Downs, Nicholas E Nacca, Andrew I Stolbach, Michael G Holland","doi":"10.1007/s13181-024-01004-1","DOIUrl":"10.1007/s13181-024-01004-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"334-335"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Asymptomatic Patients Need Endoscopy after Caustic Ingestion? 摄入腐蚀性物质后,无症状患者需要进行内窥镜检查吗?
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-27 Epub Date: 2024-04-29 DOI: 10.1007/s13181-024-01009-w
James D Whitledge, Michele M Burns
{"title":"Do Asymptomatic Patients Need Endoscopy after Caustic Ingestion?","authors":"James D Whitledge, Michele M Burns","doi":"10.1007/s13181-024-01009-w","DOIUrl":"10.1007/s13181-024-01009-w","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"254-255"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Ensuring the Efficacy and Safety of Approved Medications ". 就 "确保已批准药物的疗效和安全性 "发表评论。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-27 Epub Date: 2024-05-02 DOI: 10.1007/s13181-024-01005-0
J Oppenheimer, Thomas B Casale, Sarina Tanimoto
{"title":"Comment on \"Ensuring the Efficacy and Safety of Approved Medications \".","authors":"J Oppenheimer, Thomas B Casale, Sarina Tanimoto","doi":"10.1007/s13181-024-01005-0","DOIUrl":"10.1007/s13181-024-01005-0","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"330-331"},"PeriodicalIF":2.5,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
JMT Musings: From the Impostor Syndrome to Humility. JMT Musings:从 "冒名顶替综合症 "到 "谦逊"。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-11 Epub Date: 2024-05-28 DOI: 10.1007/s13181-024-01012-1
Leslie R Dye
{"title":"JMT Musings: From the Impostor Syndrome to Humility.","authors":"Leslie R Dye","doi":"10.1007/s13181-024-01012-1","DOIUrl":"10.1007/s13181-024-01012-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"251-253"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American College of Medical Toxicology Research Agenda 2024-2030. 美国医学毒理学学院 2024-2030 年研究议程。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-11 Epub Date: 2024-06-04 DOI: 10.1007/s13181-024-01014-z
Neeraj Chhabra, Alison Meyn, Maryann Mazer-Amirshahi, Stephanie P Carreiro, Kevin Maskell, Marielle Brenner, David H Jang, Mark B Mycyk, Paul Wax

ACMT recognizes the pivotal role of high-quality research in advancing medical science. As such, the establishment of a formal research agenda for ACMT is a leap forward in communicating the priorities of the College, its members, and the patient populations we serve. This thoughtfully crafted agenda will serve as a strategic compass for ACMT, guiding our pursuit of scientific discovery, fostering innovation, and enhancing outcomes for patients and communities affected by poisonings and exposures.

ACMT 认识到高质量的研究在推动医学科学发展中的关键作用。因此,为 ACMT 制定正式的研究议程是在传达学院、成员和我们所服务的患者群体的优先事项方面的一次飞跃。这份经过深思熟虑制定的议程将成为 ACMT 的战略指南针,指导我们追求科学发现、促进创新,并为受中毒和接触影响的患者和社区提高疗效。
{"title":"American College of Medical Toxicology Research Agenda 2024-2030.","authors":"Neeraj Chhabra, Alison Meyn, Maryann Mazer-Amirshahi, Stephanie P Carreiro, Kevin Maskell, Marielle Brenner, David H Jang, Mark B Mycyk, Paul Wax","doi":"10.1007/s13181-024-01014-z","DOIUrl":"10.1007/s13181-024-01014-z","url":null,"abstract":"<p><p>ACMT recognizes the pivotal role of high-quality research in advancing medical science. As such, the establishment of a formal research agenda for ACMT is a leap forward in communicating the priorities of the College, its members, and the patient populations we serve. This thoughtfully crafted agenda will serve as a strategic compass for ACMT, guiding our pursuit of scientific discovery, fostering innovation, and enhancing outcomes for patients and communities affected by poisonings and exposures.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"286-292"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Response to "Comment on Ensuring the Efficacy and Safety of Approved Medications". 回应 "关于确保已批准药物的疗效和安全性的评论"。
IF 2.5 4区 医学 Q3 TOXICOLOGY Pub Date : 2024-07-11 Epub Date: 2024-05-03 DOI: 10.1007/s13181-024-01006-z
Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, Jeanmarie Perrone, Lewis S Nelson
{"title":"In Response to \"Comment on Ensuring the Efficacy and Safety of Approved Medications\".","authors":"Maryann Mazer-Amirshahi, Jon B Cole, Andrew I Stolbach, Jeanmarie Perrone, Lewis S Nelson","doi":"10.1007/s13181-024-01006-z","DOIUrl":"10.1007/s13181-024-01006-z","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":" ","pages":"332-333"},"PeriodicalIF":2.5,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11288219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical Toxicology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1